Watch LIVE the focusIR May Investor webinar with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSareum Share News (SAR)

Share Price Information for Sareum (SAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.75
Bid: 41.00
Ask: 42.50
Change: 5.25 (14.38%)
Spread: 1.50 (3.659%)
Open: 37.00
High: 42.50
Low: 36.00
Prev. Close: 36.50
SAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS AND TRADING: CleanTech raises GBP520,000 in open offer

Thu, 14th Dec 2023 20:20

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Sareum Holdings PLC - Cambridge, England-based pharmaceutical company, focused on developing kinase inhibitors to treat autoimmune diseases and cancer - Says it is optimistic about its pipeline, as its focus remains on advancing its SDC-1801 therapy. Notes that it expects to receive full safety data for SDC-1801 in the first half of 2024. Says it intends to begin a phase 2 study, which will be completed by the end of 2024.

----------

Ethernity Networks Ltd - Israel-based supplier of data processing semiconductor technology for networking appliances - Says it has received a request from 5G Innovation Leaders Fund LLC to issue 61.5 million new shares pursuant to its settlement deed. In November, it issued 44.9 million shares. Says that following the issue, it will have completed its obligations. Says the new shares to be admitted will represent 21% of its issued capital.

----------

Ashoka WhiteOak Emerging Markets Trust PLC - investment trust focused on global emerging markets - Says net asset value total return for period from its IPO in May to September 30 was 2.60%, outperforming its MSCI Emerging Markets Net Return Sterling by 1.2%. Notes that its share price is performing at a 2.2% premium to NAV. Notes that its key drivers of growth were Senco Gold, Gokaldas Exports and DBS Group. Chair Martin Shenfield says: "We are delighted to present our initial Interim Report covering the period to 30 September 2023 which included the company's successful listing on the London Stock Exchange, a landmark IPO for the sector considering the significant drought of new listings in recent years. We retain the conviction outlined at the company's IPO that the investment case for emerging markets remains attractive and that the company's bottom-up investment strategy provides a highly differentiated approach to accessing this key investment theme with the objective of generating outperformance over the long term."

----------

Digital 9 Infrastructure PLC - invests in internet infrastructure, such as data centres and subsea fibre - Says it has appointed Charlotte Valeur as its interim chair. Notes that its sale of Verne Global is on track to be completed by the end of the first quarter of 2024. Valeur comments: "We remain committed to completing the sale of Verne Global and expediting the strategic review to further maximise shareholder value".

----------

CleanTech Lithium PLC - Chile-focused lithium exploration and development - Says its open offer closed for acceptances oversubscribed by 13% at GBP586,000. Notes it was required to scale back its valid applications to its maximum allowance of 2.4 million, raising a total of GBP520,000. Says it has raised a total of GBP8.5 million from its open offer and fundraising programme. Chief Executive Aldo Boitano says: "Thank you to all our shareholders who participated in the recent open offer and to those who voted at our general meeting. It is encouraging to see an active investor base and your continued support is much appreciated as we develop sustainable lithium projects in Chile. I am particularly pleased that our open offer was oversubscribed, a clear vote of confidence for the company's plans in 2024."

----------

By Harvey Dorset, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
10 Mar 2016 13:00

Sareum Holdings Unaware Of Reason For Share Price Jump

Read more
24 Feb 2016 12:25

Sareum inches closer to drug breakthrough

(ShareCast News) - Sareum Holdings was still running on the smell of an oily rag in its interim report on Wednesday, but the company was confident it was heading towards a breakthrough in its durgs under development. The AIM-traded cancer drug discovery and development business saw no revenue during

Read more
24 Feb 2016 09:40

Sareum Holdings Reports Narrowed Loss As It Focuses On CHK1 Trials

Read more
1 Feb 2016 09:14

Sareum Submits Clinical Trial Applications For Cancer Drug Candidate

Read more
15 Dec 2015 08:40

Sareum Clinical Trials Application For Cancer Drug Coming In January

Read more
8 Dec 2015 15:58

AGM, EGM Calendar - Week Ahead

Read more
26 Oct 2015 08:59

Sareum Holdings Loss Widens As It Moves Towards Clinical Trials

Read more
15 Sep 2015 08:06

Sareum Holdings Gets US, European Patents For Aurora+FLT3 Inhibitors

Read more
23 Jul 2015 09:06

Sareum Says Journal Reports On Lung And Pancreatic Cancer Treatment

Read more
17 Jun 2015 07:56

Sareum Wins Funding To Investigate Treatment Of Adolescent Leukaemia

Read more
28 May 2015 11:26

LONDON MIDDAY BRIEFING: Corporate Sponsors Join Backlash Against FIFA

Read more
28 May 2015 10:35

WINNERS & LOSERS: Sports Direct Expects Earnings To Beat Forecasts

Read more
28 May 2015 07:13

Sareum Raises GBP1.4 Million Via Discounted Share Placing (ALLISS)

Read more
12 May 2015 12:28

LONDON MIDDAY BRIEFING: EasyJet Outlook Hits Turbulence

Read more
12 May 2015 10:36

WINNERS & LOSERS: easyJet Slides As Analysts Set To Cut Forecasts

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.